Industry reports
Editor highlights

Global Biosimilars Market Analysis

RNCOS
  • Publication date: July 2011
  • Report price: $ 1 400

Get this report today!

$ 1 400 - 1 User License
$ 1 500 - Hard Copy
$ 1 500 - CD-ROM
$ 1 800 - Corporate License

Summary

Table of Contents

The global biosimilars industry has been growing stupendously since the past few years. Various factors, such as increasing healthcare costs, burgeoning aging population, high pharmaceutical expenditure, and costly drugs are driving the incessant growth of the global biosimilars industry.

According to our new research report “Global Biosimilars Market Analysis”, the global biosimilars market is anticipated to grow at a CAGR of around 52% during 2010-2015. Market growth will be driven by upcoming patent expiries and the rising drugs bill that will encourage payers to address the barriers to biosimilars’ access in order to control costs. As the governments and private players have stepped in the industry across various geographical locations, the future prospects of the market shows immense opportunities to tap on.

Our thorough study on the industry indicates that the Global Biosimilars industry has witnessed a number of product launches and mergers & acquisitions in the past few years. The main focus of the companies has been to introduce effective and quality products in the market so that it gains a worldwide acceptance.

Our report has found that as far as number of biosimilars approvals is concerned, Europe holds a numero uno position in the market. However, despite having a specific regulatory patheways for biosimilars in the regions, a very limited number of players have launched their products in this region.

On the competitive front, Sandoz is presently the global market leader in biosimilars sales (the only company to have more than two biosimilar products approved) with Teva and Hospira also developing a range of biosimilar products. Meanwhile, some Indian companies are also using their experiences within the deregulated markets to produce dossiers and products suited for the regulated markets.

The report provides extensive information and rational analysis of the global biosimilars market. It has thoroughly examined current market drivers and restraints, industrial developments, and competitive landscapes to enable clients understand the market structure and its progress in the coming years. The report also provides an insight into different biosimilars marketed products along with country-wise analysis to present an overview of the developments taking place in the global biosimilars industry. Further, a review of product introductions/innovations and recent industry activity has also been covered in the report.

RNCOS
  • Publication date: July 2011
  • Report price: $ 1 400

Get this report today!

$ 1 400 - 1 User License
$ 1 500 - Hard Copy
$ 1 500 - CD-ROM
$ 1 800 - Corporate License

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

Global Generic Drug Industry : Latest Reports

Global Markets for Generic Drugs

Global Markets for Generic Drugs

  • $ 6 650
  • Industry report
  • January 2014
  • by BCC Research

STUDY GOALS AND OBJECTIVES The aim of this report is to provide detailed market, technology and industry analyses to help readers quantify and qualify the market for prescription generic drugs. Important ...

Global Generic Drugs Market 2014-2018

Global Generic Drugs Market 2014-2018

  • $ 2 500
  • Industry report
  • March 2014
  • by Infiniti Research Limited

TechNavio's analysts forecast the Global Generic Drugs market to grow at a CAGR of 11.02 percent over the period 2013-2018. The patent expiry of top-selling drugs is one of the major drivers contributing ...

Lercanidipine: Pipeline™ Developer: Patent Report

Lercanidipine: Pipeline™ Developer: Patent Report

  • $ 2 266
  • Industry report
  • March 2014
  • by GenericsWeb

0


Global Generic Drug Industry : Latest Downloads

Global Generic Drug Market

  • Industry report
  • February 2014
  • 5 pages

Generic Drug Industry Brief

  • Industry report
  • October 2013
  • 16 pages

... September 2012) why now Office of generic drugs (ogd)/fda has been significantly under resourced for more than a decade the pharmaceutical industry has globalized requiring fda oversight ...


Related Market Segments :

Biosimilars

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.